Treatment Approaches in Pediatric Acute Myeloid Leukemia: A Narrative Review

Abstract excerpt

Pediatric acute myeloid leukemia (AML) is the second most common childhood hematologic malignancy, accounting for approximately 20% of acute leukemias in children. Although complete remission rates now approach 90% and 10-year survival exceeds 60%, relapse remains frequent and treatment-related toxicity is substantial. This narrative review provides a comprehensive overview of current treatment approaches and emer...

Topics

Open a Topic to create a Post that cites this publication.

• Child
• fms-Like Tyrosine Kinase 3
• Hematopoietic Stem Cell Transplantation
• Leukemia, Myeloid, Acute
• Molecular Targeted Therapy
• Mutation
• Prognosis
• Transplantation, Homologous

Identifiers and source

Literature Corpus work

49268865-3eca-5b38-bdcb-c5abd22a73f8

DOI

10.20944/preprints202605.2072.v1